Half Year 2025 Ilika PLC Earnings Call Transcript
Key Points
- Ilika PLC (ILIKF) has a strong patent portfolio with 62 patents, providing robust protection for its intellectual property.
- The company has a diversified market approach, targeting both medical devices and automotive sectors, which reduces execution risk.
- Ilika PLC (ILIKF) has a licensing and royalty agreement with Cirtec, validating its Stereax technology and enabling scale-up for production.
- The company has completed the commissioning of equipment at Cirtec Medical, paving the way for product release and revenue generation.
- Ilika PLC (ILIKF) has received positive feedback on its Goliath batteries, which have been tested by automotive customers and show promising safety and performance benefits.
- The company is still in the early stages of revenue generation, with initial revenues expected to be low as products undergo lab-based trials.
- Ilika PLC (ILIKF) faces challenges in providing forward guidance due to the nascent stage of its production and commercialization efforts.
- The company is reliant on grant funding, which has seen a hiatus, impacting its financial planning and cash flow management.
- There is uncertainty around the timeline for Goliath battery commercialization, as it depends on licensing discussions over the next 18 to 24 months.
- Ilika PLC (ILIKF) has experienced a decrease in turnover, primarily due to the winding down of major grant funding projects.
Good afternoon and welcome to the Ilika PLC investor presentation. (Operator Instructions) Before we begin, I'd like to submit the following poll and I now like to drove to Graham Purdy, CEO. Good afternoon, sir.
Hello. And many thanks to everybody for choosing to listen to Ilika's half-year results. I realize that you've got a news Rich Day with lots of executive orders that you could digest if you wish. But we're going to focus on what's happened in the first six months of Ilika's current financial year and talk you through the key items that are related to our Stereax and Goliath products. I'm joined today by our CFO Jason.
Good afternoon.
And together we'll whip through the presentation and take your questions. I just want to apologize for those of you who have
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
